[Federal Register Volume 68, Number 211 (Friday, October 31, 2003)]
[Notices]
[Pages 62088-62089]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-27558]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Veterinary Medicine Advisory Committee; Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

[[Page 62089]]

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Veterinary Medicine Advisory Committee. 
This meeting was announced in the Federal Register of September 18, 
2003 (68 FR 54734). The amendment is being made to reflect changes in 
the Date and Time, and the Agenda, portions of the document. 
Specifically, due to withdrawal of permission by a sponsor to discuss a 
specific fourth generation cephalosporin on November 3, 2003, the topic 
has been indefinitely postponed. Discussions on November 5, 2003, 
regarding genetic engineering research with food animals have also been 
postponed.

FOR FURTHER INFORMATION CONTACT: Aleta Sindelar, Center for Veterinary 
Medicine (CVM) (HFV-3), Food and Drug Administration, 7519 Standish 
Pl., Rockville, MD 20855, 301-827-4515, e-mail: [email protected], 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12546. Please call the 
Information Line for up-to-date information on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of September 18, 
2003, FDA announced that a meeting of the Veterinary Medicine Advisory 
Committee will be held on November 3, 4, and 5, 2003. On page 54734, in 
the second column, the Date and Time portion of the meeting is amended 
to read as follows:
    Date and Time: The meeting will be held on November 4, 2003, from 9 
a.m. to 5 p.m.
    On page 54734, in the second column, the Agenda portion of the 
meeting is amended to read as follows:
    Agenda: On November 4, 2003, the committee will hear a preview of a 
draft risk assessment on animal cloning using somatic cell nuclear 
transfer. The risk assessment addresses both animal health and 
consumption of food derived from animal clones and their progeny. 
Background information that includes a draft executive summary of the 
risk assessment will be made available to committee members and the 
public in advance of the meeting and posted on CVM's home page at 
http://www.fda.gov/cvm. A limited number of paper copies of the 
background information will be available at the registration table. The 
complete draft risk assessment document will be made available for 
public comment at a later date.

    Dated: October 28, 2003.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 03-27558 Filed 10-29-03; 1:11 pm]
BILLING CODE 4160-01-S